An interventional clinical trial evaluating INS-101 for Type II Collagen Disorders
Latest Information Update: 15 Jul 2022
At a glance
- Drugs INS-101 (Primary)
- Indications Collagen disorders
- Focus Adverse reactions
- Sponsors InnoSkel
Most Recent Events
- 15 Jul 2022 New trial record